There was no significant interaction for bleeding ( PLATO major bleeding , 1.02 [ 95 % CI 0.70-1 .49 ] vs 1.04 [ 95 % CI 0.95-1 .14 ] , P = .938 ) and other related adverse events with ticagrelor compared with clopidogrel between Asians and non-Asians .